Related references
Note: Only part of the references are listed.MiR-125b Loss Activated HIF1α/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular Carcinoma
Xiyang Wei et al.
HEPATOLOGY (2021)
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
Pranavi Koppula et al.
PROTEIN & CELL (2021)
Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma
Xiang-Ke Niu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Immune Checkpoint Inhibitors in the Treatment of HCC
Clelia Donisi et al.
FRONTIERS IN ONCOLOGY (2021)
Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
Liyun Zheng et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma
Alessandro Granito et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Ferroptosis is involved in the progression of hepatocellular carcinoma through the circ0097009/miR-1261/SLC7A11 axis
Ning Lyu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Development of TACE Refractoriness Scores in Hepatocellular Carcinoma
Li Chen et al.
FRONTIERS IN PHARMACOLOGY (2021)
Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+CD25+Foxp3+regulatory T cells in the immune microenvironment
Alessandro Granito et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer
Dongqiang Zeng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination
Benjamin C. Chandler et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Metabolism-associated molecular classification of hepatocellular carcinoma
Chen Yang et al.
MOLECULAR ONCOLOGY (2020)
Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma
Jonggi Choi et al.
PLOS ONE (2020)
ImmuCellAI: A Unique Method for Comprehensive T-Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy
Ya-Ru Miao et al.
ADVANCED SCIENCE (2020)
Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma
Hideo Takahashi et al.
CANCERS (2020)
Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinoma
Guang-Yu Ding et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
Young Chang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma
Jie-ying Liang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
The International Cancer Genome Consortium Data Portal
Junjun Zhang et al.
NATURE BIOTECHNOLOGY (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview
Huiyan Cheng et al.
FRONTIERS IN ONCOLOGY (2019)
Application of PD-1 Blockade in Cancer Immunotherapy
Xiaomo Wu et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw et al.
CANCER RESEARCH (2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
Silencing TTK expression inhibits the proliferation and progression of prostate cancer
Saipeng Chen et al.
EXPERIMENTAL CELL RESEARCH (2019)
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges
Xiufeng Liu et al.
ONCOLOGIST (2019)
The lung microenvironment: an important regulator of tumour growth and metastasis
Nasser K. Altorki et al.
NATURE REVIEWS CANCER (2019)
GSCALite: a web server for gene set cancer analysis
Chun-Jie Liu et al.
BIOINFORMATICS (2018)
Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
Soon Sun Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2018)
TIP: A Web Server for Resolving Tumor Immunophenotype Profiling
Liwen Xu et al.
CANCER RESEARCH (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Liver cancer incidence and mortality in China: Temporal trends and projections to 2030
Rongshou Zheng et al.
CHINESE JOURNAL OF CANCER RESEARCH (2018)
The evolutionary scenario of hepatocellular carcinoma in Italy: an update
Laura Bucci et al.
LIVER INTERNATIONAL (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Sorafenib: A Review in Hepatocellular Carcinoma
Gillian M. Keating
TARGETED ONCOLOGY (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Nicholas McGranahan et al.
CELL (2017)
Components of the hepatocellular carcinoma microenvironment and their role in tumor progression
M. V. Novikova et al.
BIOCHEMISTRY-MOSCOW (2017)
Lipiodol Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review of Efficacy and Safety Data
Riccardo Lencioni et al.
HEPATOLOGY (2016)
Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery
Mingsheng Huang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system
Kichang Han et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Katarzyna Tomczak et al.
Wspolczesna Onkologia-Contemporary Oncology (2015)
Surgical treatment of intra hepatic recurrence of hepatocellular carcinoma
Laurence Lacaze et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels
Paul Geeleher et al.
PLOS ONE (2014)
Recent advances in the surgical treatment of hepatocellular carcinoma
Zenichi Morise et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
How to Define Transarterial Chemoembolization Failure or Refractoriness: A European Perspective
Jean-Luc Raoul et al.
LIVER CANCER (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Hepatocellular Carcinoma from an Immunologic Perspective
Tim F. Greten et al.
CLINICAL CANCER RESEARCH (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
NCBI GEO: archive for functional genomics data sets-update
Tanya Barrett et al.
NUCLEIC ACIDS RESEARCH (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Chemoembolization for Hepatocellular Carcinoma
Riccardo Lencioni
SEMINARS IN ONCOLOGY (2012)
Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
Masatoshi Kudo et al.
DIGESTIVE DISEASES (2011)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
